|Calculated MW||37329 Da|
|Application & Usage||The peptide is used for blocking the antibody activity of active Cathepsin V. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37°C|
|Other Names||Cathepsin L2, 184.108.40.206, Cathepsin U, Cathepsin V, CTSV, CATL2, CTSL2, CTSU|
|Formulation||50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.|
|Reconstitution & Storage||-20 °C|
|Precautions||Cathepsin V Blocking Peptide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||CATL2, CTSL2, CTSU|
|Function||Cysteine protease. May have an important role in corneal physiology.|
|Tissue Location||Predominantly expressed in the thymus and testis. Also expressed in corneal epithelium, and to a lesser extent in conjunctival epithelium and skin|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.